China Pet Funding Week 2026: Hewei Tech Closes RMB 80M Series B as Tianyuan Pet Backs 15-Clinic Pet Hospital Startup
Executive Summary: Two Chinese pet-industry funding events surfaced in the week of September 21-27, 2026, per EO Intelligence data published September 28: Shenzhen omnichannel platform Hewei Tech raised RMB 80 million in Series B funding, and listed supplier Tianyuan Pet took a 7.58% stake in Hangzhou-based Zhumeng Pet, a startup operating 15 direct pet hospitals, in its angel round.
Key Facts
- Company
- Hewei Tech; Zhumeng Pet; investor Tianyuan Pet (SZSE: 301335)
- Country
- China
- Industry
- Pet supplies omnichannel platform; pet healthcare services
- Category
- Venture funding and strategic investment
- Event
- Hewei Tech RMB 80M Series B (2026-09-22); Zhumeng Pet angel round (2026-09-21)
- Date
- 2026-09-22 (per EO Intelligence weekly report published 2026-09-28)
- Location
- Shenzhen and Hangzhou, China
- Source
- EO Intelligence weekly funding report
What Happened
EO Intelligence’s consumer-sector funding weekly, published September 28, 2026, recorded two pet-industry deals in the September 21-27 window. Hewei Technology (Shenzhen) Co. completed a RMB 80 million Series B on September 22 — a round that ranks in the top half of all B rounds disclosed in China this year by size. The company operates an omnichannel pet-supplies platform combining online e-commerce, instant retail and smart unmanned stores — a one-stop destination for pet products online — and says the capital goes to warehouse and supply-chain upgrades, unmanned-store expansion, instant-retail network buildout, technology development and own-brand incubation.
The second deal links a listed manufacturer to pet healthcare. Tianyuan Pet (SZSE: 301335), the Hangzhou-listed pet products maker, invested in the angel round of Zhumeng (Hangzhou) Pet Technology, taking a 7.58% stake according to Tianyancha corporate registration data reported by StockStar on September 22. Zhumeng Pet, founded in January 2021 with 13 staff, operates 15 direct-owned pet hospitals nationwide and focuses on pet medical services and industry digitalization.
Background
Both deals say something about where Chinese pet-industry capital is going. Hewei Tech, founded in September 2017, claims the largest warehouse system in South China for pet supplies and has moved from being a supply-chain service provider to a platform that also runs its own brands — the classic Chinese playbook of supply chain first, brand later. Its B round funds exactly that: more logistics depth, plus the unmanned-store format that cuts staffing costs in a low-margin category.
Tianyuan Pet’s move is the more strategic of the two. The company has spent 2026 rebuilding itself from an OEM pet-products exporter into a domestic brand-and-channel operator, and it just won CSRC registration consent — disclosed September 24 — for its RMB 640 million acquisition of e-commerce operator Taotong Technology. The Zhumeng angel investment extends the same logic upstream into services: 16 outbound investments to date, with long-term equity holdings of RMB 123 million at the end of 2025, up 15.8% year over year.
Industry Context
Pet healthcare is the logical next battleground for Chinese pet-industry consolidators. Pet hospitals are service businesses with recurring revenue, professional staff and customer trust — assets that product companies cannot manufacture in a factory. A manufacturer that owns clinic touchpoints can route its own nutrition and supplies brands through them, close the loop on customer data, and defend margin when product price competition turns brutal. Zhumeng’s 15 hospitals are small, but as an angel-stage entry they give Tianyuan a working template for the sector.
On the retail side, Hewei Tech’s RMB 80 million is a bet that omnichannel — instant retail plus unmanned stores plus e-commerce — is the surviving format for pet supplies in China’s price-war environment. The week’s wider funding data puts the deal in proportion: EO Intelligence logged 106 funding events across all consumer sectors in the week, totaling roughly RMB 50.3 billion, with pet deals a small but strategically loud slice.
Market & Business Impact
For suppliers and brands, Hewei Tech’s expansion means another scaled channel competing for shelf and warehouse allocation in South China — potentially good for volume, uncomfortable for pricing. Every pet product distributor selling into China should note its own-brand incubation plans: today’s channel partner can become tomorrow’s competitor, a dynamic every exporter already knows from the platform era.
For the pet hospital sector, Tianyuan’s entry is a signal that clinic consolidation capital now includes manufacturers, not just PE funds and chains. Independent clinics evaluating acquisition or partnership offers should expect more product-company suitors. And for founders: an angel round from a listed strategic backer brings channel access that a pure financial investor cannot match — but also alignment risk if the startup’s roadmap drifts from the backer’s supply-chain interests.
Companies & Brands Involved
Hewei Tech — omnichannel pet supplies platform, RMB 80 million Series B. Zhumeng (Hangzhou) Pet Technology — 15-clinic pet healthcare and digitalization startup, angel round. Tianyuan Pet (SZSE: 301335) — Hangzhou-listed pet products manufacturer, angel investor and strategic consolidator, fresh from CSRC consent on the Taotong acquisition. Company profiles and directory records for all three are maintained in the GPI Company Directory.
Data & Evidence
Verified figures: RMB 80 million Series B completed September 22, 2026 (EO Intelligence company record and weekly report; ranked top-50% of 2026 B rounds by amount); angel round completed September 21, 2026 with investor Tianyuan Pet (EO Intelligence); Tianyuan stake 7.58% via Tianyancha corporate data (StockStar, September 22, 2026); Zhumeng founded January 15, 2021, 13 employees, 15 direct pet hospitals; Tianyuan outbound investments total 16 with long-term equity holdings of RMB 123 million at end-2025 (+15.8% YoY); weekly consumer-sector funding across China totaled approximately RMB 50.3 billion across 106 events (EO Intelligence). The RMB 80 million figure was also carried by China Economic News Network.
What This Means for the Pet Industry
Chinese pet-industry capital is consolidating around two poles: controlled distribution and owned services. Hewei Tech’s Series B funds warehouses and unmanned stores — infrastructure that decides who moves product at what cost. Tianyuan’s angel bet on a 15-clinic pet hospital operator funds the trust layer that decides which brands vets recommend. Watch both: the platform that owns logistics and the manufacturer that owns clinic touchpoints are building the two moats that will define China’s pet market structure through the rest of the decade. For overseas brands, the message is to secure distribution agreements before platform own-brands crowd the shelf — and for founders pitching pet startup ideas in China, strategic money from listed operators is now the fastest path to scale.
Key Takeaways
- Hewei Technology of Shenzhen completed an RMB 80 million Series B on September 22, 2026, ranking in the top half of China’s B rounds by size this year.
- Hewei Tech operates an omnichannel pet supplies platform spanning e-commerce, instant retail and smart unmanned stores, with the largest warehouse system in South China.
- Tianyuan Pet (SZSE: 301335) invested in the angel round of Zhumeng Pet, taking a 7.58% stake in the Hangzhou startup that runs 15 direct-owned pet hospitals.
- Tianyuan has made 16 outbound investments and holds RMB 123 million in long-term equity as of end-2025, up 15.8% year over year.
- EO Intelligence logged 106 consumer-sector funding events worth about RMB 50.3 billion in the week of September 21-27, 2026, with pet deals strategically prominent.
Frequently Asked Questions
What happened?
Two pet-industry funding deals were recorded in the week of September 21-27, 2026: Hewei Tech’s RMB 80 million Series B and Tianyuan Pet’s angel-round investment in 15-clinic operator Zhumeng Pet, per EO Intelligence data published September 28.
Which company raised the larger round?
Hewei Tech, which raised RMB 80 million on September 22, 2026 — a top-50% B round by size among all Chinese B rounds disclosed this year.
Who invested in Zhumeng Pet?
Tianyuan Pet (SZSE: 301335), the Hangzhou-listed pet products manufacturer, which took a 7.58% stake according to Tianyancha registration data.
What does Zhumeng Pet do?
Zhumeng (Hangzhou) Pet Technology, founded in January 2021, operates 15 direct-owned pet hospitals and builds intelligent pet medical services and industry digitalization tools.
Why is this important for the pet industry?
It shows Chinese pet capital consolidating around controlled distribution and owned healthcare services — the two moats that will shape supplier access and brand recommendations in the China market.
Sources
- Primary — EO Intelligence, Consumer Sector Funding Weekly (Sept 21-27, 2026) via Tencent News, published September 28, 2026.
- Secondary — China Economic News Network, Hewei Tech RMB 80M Series B report, cet.com.cn, September 2026.
- Secondary — StockStar, Tianyuan Pet outbound investment in Zhumeng Pet via Tianyancha data, finance.stockstar.com, September 22, 2026.
Related News & GPI Data
- GPI News Center — daily verified pet-industry intelligence
- GPI Company Directory — 90, 000+ pet-industry company records
- GPI Industry Rankings — country and category benchmarks
- GPI Compare Tool — side-by-side company and brand comparisons